The Economics of PillCam

Gastrointestinal Endoscopy Clinics of North America

Volumn 16, Issue 2, 2006, Pages 337-345

  Eisen, Glenn M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSULE ENDOSCOPY; CHRONIC LIVER DISEASE; COLONOSCOPY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; CROHN DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS VARICES; FALSE POSITIVE RESULT; FOOD AND DRUG ADMINISTRATION; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; REVIEW; SCREENING TEST;

CHRONIC DISEASE; COST-BENEFIT ANALYSIS; CROHN DISEASE; ENDOSCOPES, GASTROINTESTINAL; ENDOSCOPY, GASTROINTESTINAL; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; HUMANS; INTESTINE, SMALL; LIVER CIRRHOSIS; MINIATURIZATION; VIDEO RECORDING;

EID: 33646118216     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.giec.2006.03.006     Document Type: Review

References (52)

1. Iddan G.J., and Swain C.P. History and development of capsule endoscopy. Gastrointest Endosc Clin N Am 14 (2004) 1-9
2. US Food and Drug Administration. Center for Devices and Radiological Health. 510(k)s. Final decisions rendered for Nov 2004. Available at:. http://www.fdagov/cdrh/510k/sumnov04.html Accessed February 15, 2006
3. US Food and Drug Administration. Center for Devices and Radiological Health. 510(k)s. Final decisions rendered for Aug 2001. Available at:. http://www.fdagov/cdrh/510k/sumaug01.html
4. Swain P., Adler D., and Enns R. Capsule endoscopy in obscure intestinal bleeding. Endoscopy 37 (2005) 655-659
5. Swain P. Wireless capsule endoscopy and Crohn's disease. Gut 54 (2005) 323-326
6. Cave D. Capsule endoscopy and Crohn's disease. Gastrointest Endosc 61 (2005) 262-263
7. Kornbluth A., Legnani P., and Lewis B.S. Video capsule endoscopy in inflammatory bowel disease: past, present, and future. Inflamm Bowel Dis 10 (2004) 278-285
8. Burke C.A., Santisi J., Church J., et al. The utility of capsule endoscopy small bowel surveillance in patients with polyposis. Am J Gastroenterol 100 (2005) 1498-1502
9. Mata A., Llach J., Castells A., et al. A prospective trial comparing wireless capsule endoscopy and barium contrast series for small-bowel surveillance in hereditary GI polyposis syndromes. Gastrointest Endosc 61 (2005) 721-725
10. Schulmann K., Hollerbach S., Kraus K., et al. Feasibility and diagnostic utility of video capsule endoscopy for the detection of small bowel polyps in patients with hereditary polyposis syndromes. Am J Gastroenterol 100 (2005) 27-37
11. Caspari R., von Falkenhausen M., Krautmacher C., et al. Comparison of capsule endoscopy and magnetic resonance imaging for the detection of polyps of the small intestine in patients with familial adenomatous polyposis or with Peutz-Jeghers' syndrome. Endoscopy 36 (2004) 1054-1059
12. Soares J., Lopes L., Vilas Boas G., et al. Wireless capsule endoscopy for evaluation of phenotypic expression of small-bowel polyps in patients with Peutz-Jeghers syndrome and in symptomatic first-degree relatives. Endoscopy 36 (2004) 1060-1066
13. Pennazio M. Small-intestinal pathology on capsule endoscopy: tumors. Endoscopy 37 10 (2005) 1008-1017
14. Culliford A., Daly J., Diamond B., et al. The value of wireless capsule endoscopy in patients with complicated celiac disease. Gastrointest Endosc 62 (2005) 55-61
15. Petroniene R., Dubcenco E., Baker J.P., et al. Given capsule endoscopy in celiac disease: evaluation of diagnostic accuracy and interobserver agreement. Am J Gastroenterol 100 (2005) 685-694
16. Petroniene R., Dubcenco E., Baker J.P., et al. Given capsule endoscopy in celiac disease. Gastrointest Endosc Clin N Am 14 (2004) 115-127
17. Joyce A.M., Burns D.L., Marcello P.W., et al. Capsule endoscopy findings in celiac disease associated enteropathy-type intestinal T-cell lymphoma. Endoscopy 37 (2005) 594-596
18. Meta-analysis report: performance evaluation of Given Diagnostic System in the diagnosis of small bowel diseases and disorders. Version 2 (2003) 1-36
19. Bowel disorders detection system approved. FDA News Daily Bull 4 134 (2003)
20. Eliakim R., Shlomi I., Yassin K., et al. A novel diagnostic tool for detecting oesophageal pathology: the PillCam oesophageal video capsule. Aliment Pharmacol Ther 20 10 (2004) 1083-1089
21. Eliakim R., Sharma V.K., Yassin K., et al. PillCam esophageal capsule endoscopy (ECE) is comparable to traditional upper endoscopy (EGD) in detection of esophagitis and Barrett's esophagus in patients with GERD symptoms. J Clin Gastroenterol 39 7 (2005) 572-578
22. Eisen G.M., Eliakim R., Zaman A., et al. A pilot study of the diagnostic accuracy of Given esophageal capsule endoscopy versus conventional upper endoscopy for the diagnosis of esophageal varices. Endoscopy 38 1 (2006) 31-35
23. Lapalus M.G., Dumortier J., Fumex F., et al. Esophageal capsule endoscopy versus esophagogastroduodenoscopy for evaluating portal hypertension: a prospective comparative study of performance and tolerance. Endoscopy 38 1 (2006) 36-41
24. Lewis B. Radiology versus endoscopy of the small bowel. Gastrointest Endosc Clin N Am 9 (1999) 13-27
25. Lewis B.S., Eisen G.M., and Friedman S. A pooled analysis to evaluate results of capsule endoscopy trials. Endoscopy 37 10 (2005) 960-965
26. Goldfarb N., Phillips A., Conn M., et al. Economic and health outcomes of capsule endoscopy: opportunities for improved management of the diagnostic process for obscure gastrointestinal bleeding. Dis Manag 5 (2002) 249-253
27. Pennazio M., Santucci R., Rondonotti E., et al. Outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: report of 100 cases. Gastroenterology 126 (2004) 643-653
28. th International Conference on Capsule Endoscopy in Miami, Florida. Yoqneum, Israel: Given Imaging; 2005
29. Pennazio M., Eisen G., and Goldfarb N. International Conference on Capsule Endoscopy consensus for obscure gastrointestinal bleeding. Endoscopy 37 (2005) 1046-1050
30. Hanauer S.B., Cohen R.D., Becker III R.V., et al. Advances in the management of Crohn's disease: economic and clinical potential of infliximab. Clin Ther 20 (1998) 1009-1028
31. Triester S.L., Leighton J.A., Gurudu S.R., et al. A meta-analysis of capsule endoscopy (CE) compared to other modalities in patients with non-stricturing Crohn's disease [abstract]. Am J Gastroenterol 99 (2004) S271-S272
32. Goldstein J.L., Eisen G.M., Lewis B., et al. The use of capsule endoscopy to prospectively assess the incidence of small bowel lesions with celecoxib, naproxen plus omeprazole and placebo. Clin Gastroenterol Hepatol 3 2 (2005) 132-141
33. Goldfarb N.I., Pizzi L.T., Fuhr J.P., et al. Diagnosing Crohn's disease: an economic analysis comparing wireless capsule endoscopy with traditional diagnostic procedures. Dis Manag 7 4 (2004) 292-304
34. Locke III G.R., Talley N.J., Fett S.L., et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmstead County, Minnesota. Gastroenterology 112 (1997) 1448-1456
35. Sandler R.S., Everhart J.E., Donowitz M., et al. The burden of selected digestive diseases in the United States. Gastroenterology 122 (2002) 1500-1511
36. Eisen G.M., Lieberman D.A., Fennerty M.B., et al. Screening and surveillance in Barrett's esophagus: a call to action. Clin Gastroenterol Hepatol 10 (2004) 861-864
37. Devault K.R., and Castell D.O. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100 (2005) 190-200
38. Inadomi J.M., Sampliner R., Lagergren J., et al. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med 138 3 (2003) 176-186
39. Rubinstein J.H., Inadomi J., Eisen G.M. Cost-utility of screening for esophageal adenocarcinoma with esophageal capsule endoscopy versus conventional upper endoscopy. Gastroenterology, In press
40. Dufour M.C. Chronic liver disease and cirrhosis. In: Everhart J.E. (Ed). Digestive diseases in the United States: epidemiology and impact. NIH publication # 94-1447 (1994), US Dept of Health and Human Services, Washington (DC) 615-645
41. Cales P., Desmorat H., Vinel J.P., et al. Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding. Gut 31 (1990) 1298-1302
42. Zaman A., Becker T., Lapidus J., et al. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med 161 (2001) 2564-2570
43. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 319 (1988) 983-989
44. Gores G.J., Weisner R.H., Dickson E.R., et al. Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history and influence in survival. Gastroenterology 96 (1989) 1552-1559
45. De Franchis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 33 (2000) 846-852
46. Grace N.D. Practice guidelines: diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Am J Gastroenterol 92 (1997) 1081-1091
47. Spiegel B.M.R., Targownik L.E., Karsan H.A., et al. Endoscopic screening for esophageal varices in cirrhosis: is it ever cost-effective?. Hepatology 37 (2003) 366-377
48. Arguedas M.R., Heudebert G.R., Eloubeidi M.A., et al. Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices. Am J Gastroenterol 97 (2002) 2441-2452
49. Saab S., DeRosa V., Nieto J., et al. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model. Am J Gastroenterol 98 (2003) 763-770
50. Speigel B.M.R., Esrailian E., Eisen G.M. The budget impact of screening for esophageal varices with capsule endoscopy. Gastroenterology, In press
51. Cooke C.E., Wong W., and Lee H. Utilization and cost of sildenafil in a large managed care organization with a quantity limit on sildenafil. J Manag Care Pharm 11 (2005) 674-680
52. West D.S., Johnson J.T., and Hong S.H. A 30-month evaluation of the effects on the cost and utilization of proton pump inhibitors from adding omeprazole OTC to drug benefit coverage in a state employee health plan. J Manag Care Pharm 12 (2006) 25-32